CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Rapidly aging population
3.4.1.2. High incidence of orthopedic disorders
3.4.1.3. Rise in physical health consciousness
3.4.1.4. Improvement of healthcare infrastructure in developing countries

3.4.2. Restraint

3.4.2.1. High cost of custom orthotic devices

3.4.3. Opportunity

3.4.3.1. Lucrative opportunities in emerging economies

3.4.4. Impact analysis

3.5. PORTERS FIVE FORCES ANALYSIS

3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry

3.6. GOVERNMENT REGULATIONS

3.6.1. U.S. FDAs premarket clearance and approval requirements
3.6.2. European Union
3.6.3. Japan

CHAPTER 4 ORTHOPEDIC ORTHOTICS MARKET, BY ANATOMICAL REGION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. UPPER LIMB ORTHOTIC DEVICES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast by type
4.2.4. Market size and forecast, by region
4.2.5. Market size and forecast, by country
4.2.6. Shoulder orthotic devices

4.2.6.1. Market size and forecast

4.2.7. Hand & wrist orthotic devices

4.2.7.1. Market size and forecast

4.2.8. Elbow orthotic devices

4.2.8.1. Market size and forecast

4.2.9. Other upper limb orthotic devices

4.2.9.1. Market size and forecast

4.3. LOWER LIMB ORTHOTIC DEVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast by type
4.3.4. Market size and forecast, by region
4.3.5. Market size and forecast, by country
4.3.6. Foot & ankle orthotic devices

4.3.6.1. Market size and forecast

4.3.7. Knee orthotic devices

4.3.7.1. Market size and forecast

4.3.8. Hip orthotic devices

4.3.8.1. Market size and forecast

4.3.9. Other lower limb orthotic devices

4.3.9.1. Market size and forecast

4.4. SPINAL ORTHOTIC DEVICES

4.4.1. Key market trends
4.4.2. Growth factor and opportunities
4.4.3. Market size and forecast by type
4.4.4. Market size and forecast, by region
4.4.5. Market size and forecast, by country
4.4.6. Cervical orthotic devices

4.4.6.1. Market size and forecast

4.4.7. Lumbosacral orthotic devices

4.4.7.1. Market size and forecast

4.4.8. Thoracic-lumbo-sacral orthotic devices

4.4.8.1. Market size and forecast

4.4.9. Cervical-thoracic-lumbar-sacral orthotic devices

4.4.9.1. Market size and forecast

4.4.10. Other spinal orthotic devices

4.4.10.1. Market size and forecast

CHAPTER 5 ORTHOPEDIC ORTHOTICS MARKET, BY POSTURE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. STATIC ORTHOTIC DEVICES

5.2.1. Market size and forecast, by region
5.2.2. Market size and forecast, by country

5.3. DYNAMIC ORTHOTIC DEVICES

5.3.1. Market size and forecast, by region
5.3.2. Market size and forecast, by country

5.4. OTHER ORTHOTIC DEVICES

5.4.1. Market size and forecast, by region
5.4.2. Market size and forecast, by country

CHAPTER 6 ORTHOPEDIC ORTHOTICS MARKET, BY MANUFACTURING

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. PREFABRICATED ORTHOTIC DEVICES

6.2.1. Market size and forecast, by region
6.2.2. Market size and forecast, by country

6.3. CUSTOM FITTED

6.3.1. Market size and forecast, by region
6.3.2. Market size and forecast, by country

6.4. CUSTOM FABRICATED

6.4.1. Market size and forecast, by region
6.4.2. Market size and forecast, by country

CHAPTER 7 ORTHOPEDIC ORTHOTICS MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.

7.2.4.1. Market size and forecast

7.2.5. Canada

7.2.5.1. Market size and forecast

7.2.6. Mexico

7.2.6.1. Market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany

7.3.4.1. Market size and forecast

7.3.5. France

7.3.5.1. Market size and forecast

7.3.6. UK

7.3.6.1. Market size and forecast

7.3.7. Italy

7.3.7.1. Market size and forecast

7.3.8. Spain

7.3.8.1. Market size and forecast

7.3.9. Rest of Europe

7.3.9.1. Market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan

7.4.4.1. Market size and forecast

7.4.5. China

7.4.5.1. Market size and forecast

7.4.6. India

7.4.6.1. Market size and forecast

7.4.7. Australia

7.4.7.1. Market size and forecast

7.4.8. Rest of Asia-Pacific

7.4.8.1. Market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil

7.5.4.1. Market size and forecast

7.5.5. Saudi Arabia

7.5.5.1. Market size and forecast

7.5.6. South Africa

7.5.6.1. Market size and forecast

7.5.7. Rest of LAMEA

7.5.7.1. Market size and forecast

CHAPTER 8 COMPANY PROFILE

8.1. BAUERFEIND AG

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments

8.2. BREG, INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments

8.3. SVENSKA CELLULOSA AKTIEBOLAGET (BSN MEDICAL LUXEMBOURG GROUP HOLDING S.A R.L.)

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. DEROYAL INDUSTRIES, INC.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio

8.5. DJO, LLC

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. FILLAUER LLC

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio

8.7. HANGER, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance

8.8. SSUR HF.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. OTTO BOCK HEALTHCARE GMBH

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio

8.10. TRULIFE

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio